Dashboard
Weak Long Term Fundamental Strength with a -18.09% CAGR growth in Operating Profits over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of 0.57
- The company has been able to generate a Return on Equity (avg) of 5.02% signifying low profitability per unit of shareholders funds
With ROCE of 2.3, it has a Expensive valuation with a 2.7 Enterprise value to Capital Employed
Below par performance in long term as well as near term
Stock DNA
Cement & Cement Products
INR 6,279 Cr (Small Cap)
83.00
36
0.00%
0.90
5.19%
4.33
Total Returns (Price + Dividend) 
Latest dividend: 1 per share ex-dividend date: Aug-06-2019
Risk Adjusted Returns v/s 
Returns Beta
News

Prism Johnson Faces Shift in Market Assessment Amid Mixed Financial and Technical Signals
Prism Johnson, a key player in the Cement & Cement Products sector, has experienced a notable shift in market assessment driven by evolving technical indicators and a complex financial backdrop. While recent quarterly results highlight strong operational gains, longer-term financial metrics and technical trends present a more nuanced picture for investors.
Read More
Prism Johnson Technical Momentum Shifts Amid Cement Sector Challenges
Prism Johnson's recent market activity reveals a notable shift in technical momentum, reflecting broader challenges within the Cement & Cement Products sector. Key indicators such as MACD, RSI, and moving averages signal a bearish trend, underscoring the stock's performance relative to benchmark indices and sector peers.
Read More
Prism Johnson Forms Death Cross, Signalling Potential Bearish Trend
Prism Johnson, a player in the Cement & Cement Products sector, has recently formed a Death Cross, a technical pattern where the 50-day moving average crosses below the 200-day moving average. This development often signals a shift towards a bearish trend and suggests a weakening momentum in the stock’s price action over the medium to long term.
Read More Announcements 
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
16-Dec-2025 | Source : BSEIntimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015
Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015
28-Nov-2025 | Source : BSEDisclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015
Disclosure Under Regulation 30 Read With Clause 8 Of Para B Of Part A Of Schedule III Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Update On Ongoing Litigations
19-Nov-2025 | Source : BSEUpdate on Ongoing Litigation
Corporate Actions 
No Upcoming Board Meetings
Prism Johnson Ltd. has declared 10% dividend, ex-date: 06 Aug 19
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Sep 2025
Shareholding Compare (%holding) 
Promoters
None
Held by 7 Schemes (6.08%)
Held by 71 FIIs (3.47%)
Hathway Investments Private Limited (37.72%)
Sbi Elss Tax Saver Fund (6%)
11.2%
Quarterly Results Snapshot (Consolidated) - Sep'25 - YoY
YoY Growth in quarter ended Sep 2025 is 13.09% vs -10.74% in Sep 2024
YoY Growth in quarter ended Sep 2025 is 103.13% vs -149.14% in Sep 2024
Half Yearly Results Snapshot (Consolidated) - Sep'25
Growth in half year ended Sep 2025 is 11.50% vs -10.39% in Sep 2024
Growth in half year ended Sep 2025 is 105.49% vs -148.59% in Sep 2024
Nine Monthly Results Snapshot (Consolidated) - Dec'24
YoY Growth in nine months ended Dec 2024 is -5.45% vs 4.94% in Dec 2023
YoY Growth in nine months ended Dec 2024 is -125.04% vs 279.03% in Dec 2023
Annual Results Snapshot (Consolidated) - Mar'25
YoY Growth in year ended Mar 2025 is -1.57% vs 0.90% in Mar 2024
YoY Growth in year ended Mar 2025 is -55.87% vs 275.44% in Mar 2024






